REVIEW PAPER
Polymeric nanoparticles – a novel solution for delivery of antimicrobial agents
1
Department of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, Bialystok, Poland
2
Holy Cross Oncology Center of Kielce, Kielce, Poland
3
Doctoral Studies, Faculty of Medical and Health Sciences, Jan Kochanowski University, Kielce, Poland
4
Department of Pathophysiology and Infection Microbiology, Institute of Medical Sciences, Faculty of Medicine and Health Sciences,
Jan Kochanowski University, Kielce, Poland
Submission date: 2016-02-23
Final revision date: 2016-02-29
Acceptance date: 2016-03-01
Publication date: 2016-04-05
Medical Studies 2016;32(1):56-62
KEYWORDS
TOPICS
ABSTRACT
The increased prevalence of antibiotic-resistant pathogens requires additional efforts to develop new antimicrobial agents and alternative methods to prevent and treat infections. In response to this challenge, a variety of nanotechnology-based tools are currently being designed and thoroughly investigated. To date, a considerable number of studies have reported increased activity of antibiotic-conjugated polymeric nanoparticles against bacteria and fungi associated with various infections, including those caused by drug-resistant pathogens. Importantly, high biocompatibility of these structures coupled with enhanced biological activity and improved pharmacokinetic properties supports the potential of these nanosystems as new tools to treat infections. In this review, we summarize the synthesis of polymer-based nanoparticles and describe their mechanism of action. We also highlight the recent advances in the application of antibiotic-conjugated polymeric nanoparticles as novel antimicrobial agents.
REFERENCES (59)
1.
Esmaeili A, Ghobadianpour S. Vancomycin loaded superparamagnetic MnFe2O4 nanoparticles coated with PEGylated chitosan to enhance antibacterial activity. Int J Pharm 2016; 501: 326-30.
2.
Gannimani R, Ramesh M, Mtambo S, Pillay K, Soliman ME, Govender P. gamma-Cyclodextrin capped sil-ver nanoparticles for molecular recognition and enhancement of antibacterial activity of chloramphenicol. J Inorg Biochem 2016; 157: 15-24.
3.
Cui H, Li W, Li C, Vittayapadung S, Lin L. Liposome containing cinnamon oil with antibacterial activity against methicillin-resistant Staphylococcus aureus biofilm. Biofouling 2016; 32: 215-25.
4.
Wnorowska U, Wątek M, Durnaś B, Głuszek K, Piktel E, Niemirowicz K, Bucki R. Extracellular DNA as an essential component and therapeutic target of microbial biofilm. Studia Medyczne 2015; 31: 132-8.
5.
Surel U, Niemirowicz K, Marzec M, Savage PB, Bucki R. Ceragenins – a new weapon to fight multidrug resistant bacterial infections. Studia Medyczne 2014; 30: 207-13.
6.
Singh R, Smitha MS, Singh SP. The role of nanotechnology in combating multi-drug resistant bacteria. J Nanosci Nanotechnol 2014; 14: 4745-56.
7.
Abdelghany SM, Quinn DJ, Ingram RJ, Gilmore BF, Donnelly RF, Taggart CC, Scott CJ. Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. Int J Nanomed 2012; 7: 4053-63.
8.
Patel PA, Patravale VB. AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration. J Biomed Nanotechnol 2011; 7: 632-9.
9.
Chaudhari MB, Desai PP, Patel PA, Patravale VB. Solid lipid nanoparticles of amphotericin B (AmbiOnp): in vitro and in vivo assessment towards safe and effective oral treatment module. Drug Deliv Transl Res 2015 Dec 28 [Epub ahead of print].
10.
Casa DM, Carraro TC, de Camargo LE, Dalmolin LF, Khalil NM, Mainardes RM. Poly(L-lactide) nanoparticles reduce amphotericin B cytotoxicity and maintain its in vitro antifungal activity. J Nanosci Nanotechnol 2015; 15: 848-54.
11.
Jamil B, Habib H, Abbasi S, Nasir H, Rahman A, Reh-man A, Bokhari H, Imran M. Cefazolin loaded chitosan nanoparticles to cure multi drug resistant Gram-negative pathogens. Carbohydr Polym 2016; 136: 682-91.
12.
Cai J, Huang H, Song W, Hu H, Chen J, Zhang L, Li P, Wu R, Wu C. Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro. Int J Pharm 2015; 495: 728-37.
13.
Prasad Rao JG, Kurt E. Polymer nanoparticles: preparation techniques and size-control parameters. Progress in Polymer Science 2011; 36: 887-913.
14.
Lerch S, Dass M, Musyanovych A, Landfester K, Mailänder V. Polymeric nanoparticles of different sizes overcome the cell membrane barrier. Eur J Pharm Biopharm 2013; 84: 265-74.
15.
Mahapatro A, Singh DK. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnol 2011; 9: 55.
16.
Swierczewska M, Han HS, Kim K, Park JH, Lee S. Polysaccharide-based nanoparticles for theranostic nanomedicine. Adv Drug Deliv Rev 2015 Nov 27. pii: S0169-409X(15)00279-3. doi: 10.1016/j.addr.2015.11.015. [Epub ahead of print].
17.
Peng Q, Mu H. The potential of protein-nanomaterial interaction for advanced drug delivery. J Control Release 2016; 225: 121-32.
18.
Singh D, Han SS, Shin EJ. Polysaccharides as nanocarriers for therapeutic applications. J Biomed Nanotechnol 2014; 10: 2149-72.
19.
Herrera Estrada LP, Champion JA. Protein nanoparticles for therapeutic protein delivery. Biomater Sci 2015; 3: 787-99.
20.
Lee JI, Yoo HS. Biodegradable microspheres containing poly(epsilon-caprolactone)-Pluronic block copolymers for temperature-responsive release of proteins. Colloids Surf B Biointerfaces 2008; 61: 81-7.
21.
Kumar N, Ravikumar MN, Domb AJ. Biodegradable block copolymers. Adv Drug Deliv Rev 2001; 53: 23-44.
22.
Luo YY, Xiong XY, Tian Y, Li ZL, Gong YC, Li YP. A review of biodegradable polymeric systems for oral insulin delivery. Drug Deliv 2015 Jun 24: 1-10. [Epub ahead of print].
23.
Palza H. Antimicrobial polymers with metal nanoparticles. Int J Mol Sci 2015; 16: 2099-116.
24.
Moritz M, Geszke-Moritz M. Recent developments in the application of polymeric nanoparticles as drug carriers. Adv Clin Exp Med 2015; 24: 749-58.
25.
Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 2009; 26: 1025-58.
26.
Ambruosi A, Khalansky AS, Yamamoto H, Gelperina SE, Begley DJ, Kreuter J. Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats. J Drug Target 2006; 14: 97-105.
27.
Al Zaki A, Hui JZ, Higbee E, Tsourkas A. Biodistribution, clearance, and toxicology of polymeric micelles loaded with 0.9 or 5 nm gold nanoparticles. J Biomed Nanotechnol 2015; 11: 1836-46.
28.
Chawla R, Solanki HS, Kheruka SC, Gambhir S, Dube V, Aggarwal LM, Mishra B. Polylactide-co-glycolide nanoparticles of antitubercular drugs: formulation, characterization and biodistribution studies. Ther Deliv 2014; 5: 1247-59.
29.
Yu H, Tang Z, Zhang D, Song W, Zhang Y, Yang Y. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy. J Control Release 2015; 205: 89-97.
30.
Akagi T, Kaneko T, Kida T, Akashi M. Multifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly(gamma-glutamic acid). J Biomater Sci Polym Ed 2006; 17: 875-92.
31.
Grabnar PA, Kristl J. The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers. J Microencapsul 2011; 28: 323-35.
32.
Pang X, Jiang Y, Xiao Q, Leung AW, Hua H, Xu C. pH-responsive polymer-drug conjugates: design and progress. J Control Release 2016; 222: 116-29.
33.
Khan H, Shukla RN, Bajpai AK. Genipin-modified gelatin nanocarriers as swelling controlled drug delivery system for in vitro release of cytarabine. Mater Sci Eng C Mater Biol Appl 2016; 61: 457-65.
34.
Boer GJ, Kruisbrink J. A polymeric controlled drug delivery device for peptides based on a surface desorption/diffusion mechanism. Biomaterials 1987; 8: 265-74.
35.
Wilczewska A, Markiewicz K. Surface-initiated RAFT/MADIX polymerization on Xanthate-coated iron oxide nanoparticles. Macromolecular Chemistry and Physics 2014; 215: 190-7.
36.
Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 2012; 161: 505-22.
37.
Gao W, Thamphiwatana S, Angsantikul P, Zhang L. Nanoparticle approaches against bacterial infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2014; 6: 532-47.
38.
Umamaheshwari RB, Jain NK. Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori. J Drug Target 2003; 11: 415-23; discussion 23-4.
39.
Jain SK, Jangdey MS. Lectin conjugated gastroretentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori. Mol Pharm 2009; 6: 295-304.
40.
Satishkumar R, Vertegel AA. Antibody-directed targeting of lysostaphin adsorbed onto polylactide nanoparticles increases its antimicrobial activity against S. aureus in vitro. Nanotechnology 2011; 22: 505103.
41.
Tay LL, Huang PJ, Tanha J, Ryan S, Wu X, Hulse J, Chau LK. Silica encapsulated SERS nanoprobe conjugated to the bacteriophage tailspike protein for targeted detection of Salmonella. Chem Commun (Camb) 2012; 48: 1024-6.
42.
He X, Li Y, He D, Wang K, Shangguan J, Shi H. Aptamer-fluorescent silica nanoparticles bioconjugates based dual-color flow cytometry for specific detection of Staphylococcus aureus. J Biomed Nanotechnol 2014; 10: 1359-68.
43.
Qin D, He X, Wang K, Tan W. Using fluorescent nanoparticles and SYBR Green I based two-color flow cytometry to determine Mycobacterium tuberculosis avoiding false positives. Biosens Bioelectron 2008; 24: 626-31.
44.
He X, Zhou L, He D, Wang K, Cao J. Rapid and ultrasensitive E. coli O157:H7 quantitation by combination of ligan dmagnetic nanoparticles enrichment with fluorescent nanoparticles based two-color flow cytometry. Analyst 2011; 136: 4183-91.
45.
Barreras US, Méndez FT, Martínez RE, Valencia CS, Rodríguez PR, Rodríguez JP. Chitosan nanoparticles enhance the antibacterial activity of chlorhexidine in collagen membranes used for periapical guided tissue regeneration. Mater Sci Eng C Mater Biol Appl 2016; 58: 1182-7.
46.
Hussein-Al-Ali SH, El Zowalaty ME, Hussein MZ, Ismail M, Webster TJ. Synthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibiotic. Int J Nanomed 2014; 9: 549-57.
47.
Cheow WS, Hadinoto K. Antibiotic polymeric nanoparticles for biofilm-associated infection therapy. Methods Mol Biol 2014; 1147: 227-38.
48.
Forier K, Raemdonck K, De Smedt SC, Demeester J, Coenye T, Braeckmans K. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J Control Release 2014; 190: 607-23.
49.
Costa JR, Silva NC, Sarmento B, Pintado M. Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin. Eur J Clin Microbiol Infect Dis 2015; 34: 1255-62.
50.
Italia JL, Yahya MM, Singh D, Ravi Kumar MN. Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone. Pharm Res 2009; 26: 1324-31.
51.
Tang X, Zhu H, Sun L, Hou W, Cai S, Zhang R, Liu F. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo. Int J Nanomed 2014; 9: 5403-13.
52.
de Carvalho RF, Ribeiro IF, Miranda-Vilela AL, de Souza Filho J, Martins OP, Cintra e Silva DeO, Tedesco AC, Lacava ZG, Bao SN, Sampaio RN. Leishmanicidal activity of amphotericin B encapsulated in PLGA-DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL/6 mice. Exp Parasitol 2013; 135: 217-22.
53.
Tange RA, Dreschler WA, Prins JM, Büller HR, Kuijper EJ, Speelman P. Ototoxicity and nephrotoxicity of gentamicin vs netilmicin in patients with serious infections. A randomized clinical trial. Clin Otolaryngol Allied Sci 1995; 20: 118-23.
54.
Zaki NM, Hafez MM. Enhanced antibacterial effect of ceftriaxone sodium-loaded chitosan nanoparticles against intracellular Salmonella typhimurium. AAPS Pharm Sci Tech 2012; 13: 411-21.
55.
Turos E, Shim JY, Wang Y, Greenhalgh K, Reddy GS, Dickey S, Lim DV. Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents. Bioorg Med Chem Lett 2007; 17: 53-6.
56.
Ong W, Nowak P, Cu Y, Schopf L, Bourassa J, Enlow E, Moskowitz SM, Chen H. Sustained pulmonary delivery of a water-soluble antibiotic without encapsulating carriers. Pharm Res 2016; 33: 563-72.
57.
Parwe SP, Chaudhari PN, Mohite KK, Selukar BS, Nande SS, Garnaik B. Synthesis of ciprofloxacin-conjugated poly (L-lactic acid) polymer for nanofiber fabrication and antibacterial evaluation. Int J Nanomed 2014; 9: 1463-77.
58.
Posadowska U, Brzychczy-Wloch M, Pamula E. Injectable gellan gum-based nanoparticles-loaded system for the local delivery of vancomycin in osteomyelitis treatment. J Mater Sci Mater Med 2016; 27: 9.
59.
Posadowska U, Brzychczy-Włoch M, Drożdż A, Krok-Borkowicz M, Włodarczyk-Biegun M, Dobrzyński P, Chrzanowski W, Pamuła E. Injectable hybrid delivery system composed of gellan gum, nanoparticles and gentamicin for the localized treatment of bone infections. Expert Opin Drug Deliv 2016 Feb 16: 1-8 [Epub ahead of print].
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
